Ramucirumab Not Yet Recruiting Phase 2 Trials for Stage IV Lung Cancer AJCC v8 / Lung Squamous Cell Carcinoma / Recurrent Lung Carcinoma / Stage IVA Lung Cancer AJCC v8 / Stage IVB Lung Cancer AJCC v8 Treatment

IndicationsStatusPurposePhase
Not Yet RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT04267913Testing of TAK228 (MLN0128, Sapanisertib) Plus Docetaxel to the Usual Standard of Care for Advanced Squamous Cell Lung Cancer (A Lung-MAP Treatment Trial)